|
US2685553A
(en)
|
1951-03-30 |
1954-08-03 |
Winthrop Stearns Inc |
Cement coated tablets
|
|
DE2010416B2
(de)
|
1970-03-05 |
1979-03-29 |
Hoechst Ag, 6000 Frankfurt |
Oral anwendbare Arzneiform mit Retardwirkung
|
|
DE2815926A1
(de)
|
1978-04-13 |
1979-10-18 |
Boehringer Mannheim Gmbh |
Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
CA1018456A
(en)
|
1972-06-26 |
1977-10-04 |
Hans Lowey |
Prolonged release lozenges
|
|
JPS5518694B2
(OSRAM)
|
1973-04-02 |
1980-05-21 |
|
|
|
US4034758A
(en)
|
1975-09-08 |
1977-07-12 |
Alza Corporation |
Osmotic therapeutic system for administering medicament
|
|
US4330338A
(en)
|
1978-10-02 |
1982-05-18 |
Purdue Research Foundation |
Pharmaceutical coating composition, and preparation and dosages so coated
|
|
US4449983A
(en)
|
1982-03-22 |
1984-05-22 |
Alza Corporation |
Simultaneous delivery of two drugs from unit delivery device
|
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
|
DE3320583A1
(de)
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
|
AU591171B2
(en)
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
|
US4844984A
(en)
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
|
JPH0246008B2
(ja)
|
1984-06-01 |
1990-10-12 |
Takada Seiyaku Kk |
Nifuejipinjizokuseiseizainoseizohoho
|
|
GB2170104A
(en)
|
1985-01-30 |
1986-07-30 |
Warner Lambert Co |
Coated pharmaceutical dosage forms
|
|
IE59066B1
(en)
|
1985-02-19 |
1993-12-15 |
Key Pharma |
Controlled release potassium chloride
|
|
US4898733A
(en)
|
1985-11-04 |
1990-02-06 |
International Minerals & Chemical Corp. |
Layered, compression molded device for the sustained release of a beneficial agent
|
|
US4892742A
(en)
|
1985-11-18 |
1990-01-09 |
Hoffmann-La Roche Inc. |
Controlled release compositions with zero order release
|
|
US4824675A
(en)
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
|
EP0406315B1
(en)
|
1988-03-24 |
1992-11-11 |
Bukh Meditec A/S |
Controlled release composition
|
|
FI101344B1
(fi)
|
1988-03-31 |
1998-06-15 |
Tanabe Seiyaku Co |
Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
|
|
JPH07100191B2
(ja)
|
1989-01-04 |
1995-11-01 |
古河電気工業株式会社 |
ブランキング方法
|
|
EP0455648B1
(en)
|
1989-01-30 |
1993-03-10 |
Alza Corporation |
Dosage form for administering calcium antagonist
|
|
US5019396A
(en)
|
1989-05-12 |
1991-05-28 |
Alza Corporation |
Delivery dispenser for treating cardiac arrhythmias
|
|
DK469989D0
(da)
|
1989-09-22 |
1989-09-22 |
Bukh Meditec |
Farmaceutisk praeparat
|
|
IT1237904B
(it)
|
1989-12-14 |
1993-06-18 |
Ubaldo Conte |
Compresse a rilascio a velocita' controllata delle sostanze attive
|
|
ATE113826T1
(de)
|
1989-12-29 |
1994-11-15 |
Bristol Myers Squibb Co |
Kombination einer kapsel und kaplet.
|
|
US5102668A
(en)
|
1990-10-05 |
1992-04-07 |
Kingaform Technology, Inc. |
Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
|
|
GB9025372D0
(en)
|
1990-11-22 |
1991-01-09 |
Nat Res Dev |
Pharmaceutical dosage forms
|
|
GB9101502D0
(en)
|
1991-01-23 |
1991-03-06 |
Controlled Therapeutics Sct |
Controlled release compositions
|
|
US5656295A
(en)
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
SE9202250D0
(sv)
|
1992-07-29 |
1992-07-29 |
Gacell Lab Ab |
Controlled release morphine preparation
|
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
|
US5869097A
(en)
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
|
US5881926A
(en)
|
1993-03-11 |
1999-03-16 |
Taro Pharmaceutical Industries, Ltd. |
Pharmaceutical compositions in semisolid form and a device for administration thereof
|
|
US5656291A
(en)
|
1994-03-16 |
1997-08-12 |
Pharmacia & Upjohn Aktiebolag |
Controlled release preparation
|
|
SE9301057L
(sv)
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
|
US5879705A
(en)
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
|
US6183778B1
(en)
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
|
US5419917A
(en)
|
1994-02-14 |
1995-05-30 |
Andrx Pharmaceuticals, Inc. |
Controlled release hydrogel formulation
|
|
EP0746310B1
(en)
|
1994-02-23 |
1998-11-18 |
BM Research A/S |
Controlled release composition
|
|
US7060293B1
(en)
|
1994-05-25 |
2006-06-13 |
Purdue Pharma |
Powder-layered oral dosage forms
|
|
US6077533A
(en)
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
US5460826A
(en)
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
|
US6491945B1
(en)
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
IL116674A
(en)
|
1995-01-09 |
2003-05-29 |
Mendell Co Inc Edward |
Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
|
|
WO1997001331A2
(en)
|
1995-06-27 |
1997-01-16 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
|
DK0914097T3
(da)
|
1996-03-12 |
2002-04-29 |
Alza Corp |
Sammensætning og doseringsform omfattende opioid antagonist
|
|
EP0908181B8
(en)
|
1996-05-20 |
2009-04-15 |
Otsuka Pharmaceutical Co., Ltd. |
Remedy for rosacea
|
|
US6348216B1
(en)
|
1996-06-10 |
2002-02-19 |
Knoll Pharmaceutical Company |
Ibuprofen and narcotic analgesic compositions
|
|
US6361794B1
(en)
|
1996-06-12 |
2002-03-26 |
Basf Corporation |
Method of making ibuprofen and narcotic analgesic composition
|
|
WO1998006385A1
(de)
|
1996-08-15 |
1998-02-19 |
Losan Pharma Gmbh |
Gut schluckbare orale arzneiform
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
JP2000514101A
(ja)
|
1997-07-01 |
2000-10-24 |
ファイザー・インク |
セルトラリン塩及びセルトラリンの持続性剤形
|
|
US6730326B2
(en)
|
1997-07-22 |
2004-05-04 |
Roche Diagnostics Gmbh |
Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
|
|
US6607751B1
(en)
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
|
US6066339A
(en)
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
|
US20020054911A1
(en)
|
2000-05-11 |
2002-05-09 |
Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi |
Novel oral dosage form for carvedilol
|
|
AU773642C
(en)
|
1997-12-22 |
2006-04-06 |
Mundipharma Pty Limited |
Opioid agonist/antagonist combinations
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
FR2774910B1
(fr)
|
1998-02-16 |
2001-09-07 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
|
|
US8524277B2
(en)
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6350470B1
(en)
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
|
ES2221370T3
(es)
|
1998-04-03 |
2004-12-16 |
Egalet A/S |
Composicion de liberacion controlada.
|
|
US7906143B1
(en)
|
1998-10-05 |
2011-03-15 |
Intellipharmaceutics Corp |
Controlled release pharmaceutical delivery device and process for preparation thereof
|
|
US20080102121A1
(en)
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
|
US20080113025A1
(en)
|
1998-11-02 |
2008-05-15 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
|
ATE433318T1
(de)
|
1999-02-10 |
2009-06-15 |
Pfizer Prod Inc |
Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
|
|
CA2328614C
(en)
|
1999-02-12 |
2012-06-26 |
Biostream, Inc. |
Matrices for drug delivery and methods for making and using the same
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
FR2794646B1
(fr)
|
1999-06-09 |
2001-09-21 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de preparation et composition les contenant
|
|
US6225343B1
(en)
|
1999-06-16 |
2001-05-01 |
Nastech Pharmaceutical Company, Inc. |
Compositions and methods comprising morphine gluconate
|
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
|
US6534085B1
(en)
|
1999-09-23 |
2003-03-18 |
Bioresponse L.L.C. |
Phytochemicals for promoting weight loss
|
|
KR20020059653A
(ko)
|
1999-10-29 |
2002-07-13 |
그린 마틴, 브라이언 쥐 테슬리 |
서방성 하이드로코돈 제형
|
|
US6515010B1
(en)
|
1999-11-15 |
2003-02-04 |
Smithkline Beecham Corporation |
Carvedilol methanesulfonate
|
|
US6458824B1
(en)
|
1999-11-30 |
2002-10-01 |
Dainippon Pharmaceutical Co., Ltd. |
Solid preparation
|
|
US6352721B1
(en)
|
2000-01-14 |
2002-03-05 |
Osmotica Corp. |
Combined diffusion/osmotic pumping drug delivery system
|
|
US6491949B2
(en)
|
2000-01-14 |
2002-12-10 |
Osmotica Corp. |
Osmotic device within an osmotic device
|
|
US20010053791A1
(en)
|
2000-03-16 |
2001-12-20 |
Babcock Walter C. |
Glycogen phosphorylase inhibitor
|
|
CA2402336C
(en)
|
2000-04-03 |
2008-03-11 |
F. Hoffmann-La Roche Ag |
Concentrated solutions of carvedilol
|
|
US20010036959A1
(en)
|
2000-04-03 |
2001-11-01 |
Gabel Rolf Dieter |
Carvedilol-hydrophilic solutions
|
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
EP1335707A4
(en)
|
2000-10-24 |
2005-07-06 |
Smithkline Beecham Corp |
NEW CARVEDILOL FORMULATIONS
|
|
US6733783B2
(en)
|
2000-10-30 |
2004-05-11 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
CA2363902C
(en)
|
2000-12-07 |
2005-07-26 |
Warner-Lambert Company |
Process and system for controlled-release drug delivery
|
|
US6800668B1
(en)
|
2001-01-19 |
2004-10-05 |
Intellipharmaceutics Corp. |
Syntactic deformable foam compositions and methods for making
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
|
IN191028B
(OSRAM)
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
BR0212020A
(pt)
*
|
2001-08-06 |
2005-08-16 |
Euro Celtique Sa |
Formas de dosagem, métodos para impedir o abuso de uma forma de dosagem, métodos para impedir o desvio de uma forma de dosagem, métodos para o tratamento de dor e método de preparação de uma forma de dosagem
|
|
US7144587B2
(en)
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
|
DE60224293T2
(de)
|
2001-09-21 |
2008-12-11 |
Egalet A/S |
Feste dispersionen mit kontrollierter freisetzung von carvedilol
|
|
US20040253310A1
(en)
|
2001-09-21 |
2004-12-16 |
Gina Fischer |
Morphine polymer release system
|
|
WO2003024429A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Polymer release system
|
|
CA2461682A1
(en)
|
2001-09-28 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Composite dosage forms
|
|
US20060039958A1
(en)
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
ITMI20012366A1
(it)
|
2001-11-09 |
2003-05-09 |
Farmatron Ltd |
Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
|
|
AU2003217367B2
(en)
|
2002-02-08 |
2005-09-08 |
Alkermes Controlled Therapeutics, Inc. |
Polymer-based compositions for sustained release
|
|
ITMI20020514A1
(it)
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
|
PL223471B1
(pl)
|
2002-03-15 |
2016-10-31 |
Cypress Bioscience Inc |
Kompozycja farmaceutyczna zawierająca milnacypran do stosowania w leczeniu zespołu nadwrażliwości jelita grubego
|
|
SI1578350T1
(sl)
|
2002-03-26 |
2009-10-31 |
Euro Celtique Sa |
Z gelom obloženi sestavki z zadržanim sproščanjem
|
|
US8017150B2
(en)
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
NZ536252A
(en)
|
2002-04-29 |
2007-06-29 |
Alza Corp |
Methods and dosage forms for controlled delivery of oxycodone
|
|
DE10223844B4
(de)
|
2002-05-28 |
2013-04-04 |
Danfoss A/S |
Wasserhydraulische Maschine
|
|
CA2487786A1
(en)
|
2002-05-31 |
2003-12-11 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
|
AR039744A1
(es)
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
US6632832B1
(en)
|
2002-09-10 |
2003-10-14 |
Dabur Research Foundation |
Anti-cancer activity of carvedilol and its isomers
|
|
US20040089605A1
(en)
|
2002-11-08 |
2004-05-13 |
Harry Brandt |
Reverse osmosis liquid purification system and method
|
|
AU2003275953A1
(en)
|
2002-11-08 |
2004-06-07 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
US20040102476A1
(en)
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
|
HUE026034T2
(en)
|
2002-12-13 |
2016-05-30 |
Durect Corp |
Oral delivery system containing an oral high-viscosity carrier
|
|
US20040224020A1
(en)
|
2002-12-18 |
2004-11-11 |
Schoenhard Grant L. |
Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
|
|
ATE399538T1
(de)
|
2003-03-26 |
2008-07-15 |
Egalet As |
Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
|
|
EP1610767B1
(en)
|
2003-03-26 |
2011-01-19 |
Egalet A/S |
Morphine controlled release system
|
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
CA2519556C
(en)
|
2003-04-21 |
2011-01-18 |
Benjamin Oshlack |
Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
|
|
CA2523158C
(en)
|
2003-04-24 |
2010-11-16 |
Jagotec Ag |
Delayed release tablet with defined core geometry
|
|
US20060177507A1
(en)
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
|
US8029822B2
(en)
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
|
CA2544776C
(en)
|
2003-05-28 |
2014-04-15 |
Monosolrx Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
TWI357815B
(en)
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
|
US20060165790A1
(en)
|
2003-06-27 |
2006-07-27 |
Malcolm Walden |
Multiparticulates
|
|
CA2533165A1
(en)
|
2003-07-21 |
2005-01-27 |
Bio-Dar Ltd. |
Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention
|
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE102004020220A1
(de)
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
ES2407143T3
(es)
|
2003-08-06 |
2013-06-11 |
Grünenthal GmbH |
Forma de dosificación protegida contra un posible abuso
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US20050053655A1
(en)
|
2003-09-05 |
2005-03-10 |
Pharmaceutical Industry Technology And Development Center |
Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
|
|
MXPA06003100A
(es)
|
2003-09-19 |
2006-06-20 |
Penwest Pharmaceuticals Co |
Formas de dosis de liberacion retardada.
|
|
MXPA06003454A
(es)
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Formulaciones de liberacion controlada de analgesicos opioides y no opiodes.
|
|
US20050074493A1
(en)
|
2003-10-03 |
2005-04-07 |
Mehta Atul M. |
Extended release formulations of opioids and method of use thereof
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
US8883204B2
(en)
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
|
ATE374071T1
(de)
|
2003-12-17 |
2007-10-15 |
Ksb Ag |
Drucktauschersystem
|
|
CN1905856A
(zh)
|
2003-12-23 |
2007-01-31 |
阿尔扎公司 |
用于增加受控递送的药物组合物的溶解度的方法和剂型
|
|
EP1732513A2
(en)
|
2003-12-31 |
2006-12-20 |
Alpharma, Inc. |
Rosiglitazone formulations
|
|
PL1740156T3
(pl)
|
2004-04-22 |
2011-12-30 |
Gruenenthal Gmbh |
Sposób wytwarzania zabezpieczonej przed nadużyciem, stałej postaci aplikacyjnej
|
|
ES2517244T3
(es)
|
2004-05-11 |
2014-11-03 |
Egalet Ltd. |
Forma farmacéutica hinchable que comprende goma gellan
|
|
HUE037643T2
(hu)
|
2004-06-12 |
2018-09-28 |
Collegium Pharmaceutical Inc |
Visszaélésre nem alkalmas gyógyszerkészítmények
|
|
WO2006002884A1
(de)
|
2004-07-01 |
2006-01-12 |
Grünenthal GmbH |
Gegen missbrauch gesicherte, orale darreichtungsform
|
|
DE102004032103A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
PL1765298T3
(pl)
|
2004-07-01 |
2013-01-31 |
Gruenenthal Gmbh |
Sposób wytwarzania stałej postaci dawkowania, która jest zabezpieczona przez nadużywaniem, wykorzystujący wytłaczarkę z przekładnią planetarną
|
|
CA2572352A1
(en)
|
2004-07-01 |
2006-01-12 |
Gruenenthal Gmbh |
Oral dosage form safeguarded against abuse containing (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
|
|
DE102004038440A1
(de)
|
2004-08-07 |
2006-03-16 |
Ksb Aktiengesellschaft |
Drehzahlregelbarer Druckaustauscher
|
|
US7214315B2
(en)
|
2004-08-20 |
2007-05-08 |
Scott Shumway |
Pressure exchange apparatus with integral pump
|
|
WO2006026504A2
(en)
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
|
WO2006030402A2
(en)
|
2004-09-17 |
2006-03-23 |
Ranbaxy Laboratories Limited |
Dual compartment osmotic delivery device
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20070231268A1
(en)
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060177380A1
(en)
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
FR2889810A1
(fr)
|
2005-05-24 |
2007-02-23 |
Flamel Technologies Sa |
Forme medicamenteuse orale, microparticulaire, anti-mesurage
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
KR100822519B1
(ko)
|
2005-02-15 |
2008-04-16 |
주식회사종근당 |
위장 내에서 제어방출되는 단일 매트릭스 정제
|
|
US20060193912A1
(en)
|
2005-02-28 |
2006-08-31 |
Penwest Pharmaceuticals Co. |
Controlled release O-desmethylvenlafaxine formulations
|
|
CA2599386A1
(en)
|
2005-03-28 |
2006-10-05 |
Orexo Ab |
New pharmaceutical compositions useful in the treatment of pain
|
|
GB0506982D0
(en)
|
2005-04-06 |
2005-05-11 |
Mw Encap Ltd |
Abuse resistant capsules
|
|
EP1895989A2
(en)
|
2005-06-03 |
2008-03-12 |
Egalet A/S |
A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
|
|
PE20070325A1
(es)
|
2005-06-29 |
2007-05-12 |
Alza Corp |
Formas de dosificacion oral que comprenden compuestos derivados de carbamato
|
|
US8858993B2
(en)
|
2005-07-25 |
2014-10-14 |
Metrics, Inc. |
Coated tablet with zero-order or near zero-order release kinetics
|
|
US20080166407A1
(en)
|
2005-07-29 |
2008-07-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
|
EP1931305A2
(en)
|
2005-09-09 |
2008-06-18 |
MonoSolRX, LLC |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
US8652529B2
(en)
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
EP1991207A2
(en)
*
|
2006-01-21 |
2008-11-19 |
Abbott GmbH & Co. KG |
Dosage form and method for the delivery of drugs of abuse
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20070264346A1
(en)
|
2006-02-16 |
2007-11-15 |
Flamel Technologies |
Multimicroparticulate pharmaceutical forms for oral administration
|
|
ZA200807571B
(en)
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
|
EP1993519A4
(en)
|
2006-03-15 |
2011-12-21 |
Acura Pharmaceuticals Inc |
METHOD AND COMPOSITIONS FOR PREVENTING THE ABUSE OF ORGANIC PRODUCTS MANIPULATED ORAL
|
|
DK2018160T3
(da)
|
2006-03-16 |
2012-02-06 |
Tris Pharma Inc |
Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
|
|
WO2007112286A2
(en)
|
2006-03-24 |
2007-10-04 |
Auxilium Pharmaceuticals, Inc. |
Stabilized compositions containing alkaline labile drugs
|
|
AU2007230729B2
(en)
|
2006-03-24 |
2011-07-28 |
Auxilium International Holdings, Inc. |
Process for the preparation of a hot-melt extruded laminate
|
|
PL2457562T3
(pl)
|
2006-05-09 |
2017-09-29 |
Mallinckrodt Llc |
Stałe postacie dawkowania leku o zmodyfikowanym uwalnianiu o kinetyce rzędu zerowego
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
FR2901478B1
(fr)
|
2006-05-24 |
2015-06-05 |
Flamel Tech Sa |
Forme pharmaceutique orale multimicroparticulaire a liberation prolongee
|
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
KR20090023729A
(ko)
|
2006-06-23 |
2009-03-05 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 멜록시캄 및 조절 방출형 하이드로코돈을 포함하는 조성물
|
|
EP2032137A2
(en)
|
2006-06-23 |
2009-03-11 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
|
US8465776B2
(en)
|
2006-08-04 |
2013-06-18 |
Ethypharm |
Granule and orally disintegrating tablet comprising oxycodone
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
WO2008027442A2
(en)
|
2006-08-30 |
2008-03-06 |
Theraquest Biosciences, Llc |
Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
|
|
WO2008028047A2
(en)
|
2006-08-30 |
2008-03-06 |
Lab International Srl |
Bioadhesive film drug delivery system
|
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
US8211905B1
(en)
|
2007-05-22 |
2012-07-03 |
Pisgah Laboratories, Inc. |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
|
|
DE102006057364B4
(de)
|
2006-12-04 |
2011-08-25 |
Danfoss A/S |
Wasserhydraulische Maschine
|
|
SI2101740T1
(sl)
|
2006-12-04 |
2014-03-31 |
Orexo Ab |
Nov nezlorabljiv farmacevtski sestavek, obsegajoč opiode
|
|
AU2008207200B2
(en)
|
2007-01-16 |
2011-02-17 |
Egalet Ltd |
Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
US8329720B1
(en)
|
2007-05-22 |
2012-12-11 |
Pisgah Laboratories, Inc. |
Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties
|
|
WO2008148798A2
(en)
|
2007-06-04 |
2008-12-11 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
ES2611794T3
(es)
|
2007-09-13 |
2017-05-10 |
Cima Labs Inc. |
Formulación de medicamentos resistentes al abuso
|
|
CA2959274C
(en)
|
2007-12-06 |
2019-07-09 |
Pain Therapeutics, Inc. |
Micronized opioid compositions, formulations and dosage forms and methods of making same
|
|
JP2011506318A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
経口医薬製剤
|
|
CN101969930A
(zh)
|
2007-12-17 |
2011-02-09 |
莱博法姆公司 |
防滥用控制释放制剂
|
|
JP5774853B2
(ja)
|
2008-01-25 |
2015-09-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
医薬投薬形
|
|
KR101094231B1
(ko)
|
2008-02-18 |
2011-12-14 |
하나제약 주식회사 |
서방성 고형 제제 및 그의 제조방법
|
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
CN102105136B
(zh)
|
2008-03-11 |
2014-11-26 |
蒂宝制药公司 |
包含非-阿片类止痛剂和阿片类止痛剂的组合的胃滞留型缓释剂型
|
|
US20110142905A1
(en)
|
2008-08-14 |
2011-06-16 |
Bioneer A/S |
Coated tablets with remaining degradation surface over the time
|
|
DE102008044869A1
(de)
|
2008-08-29 |
2010-03-04 |
Danfoss A/S |
Umkehrosmosevorrichtung
|
|
NZ592276A
(en)
|
2008-09-18 |
2012-12-21 |
Purdue Pharma Lp |
PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(epsilon-CAPROLACTONE) AND AN OPIOID
|
|
US8460640B2
(en)
|
2008-12-12 |
2013-06-11 |
Paladin Labs, Inc. |
Narcotic drug formulations with decreased abuse potential
|
|
JP5667575B2
(ja)
|
2008-12-16 |
2015-02-12 |
パラディン ラブス インコーポレーテッド |
誤用を防止する放出制御製剤
|
|
NZ594071A
(en)
*
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
CA2751667C
(en)
|
2009-02-06 |
2016-12-13 |
Egalet Ltd. |
Immediate release composition resistant to abuse by intake of alcohol
|
|
NZ594208A
(en)
|
2009-02-06 |
2012-10-26 |
Egalet Ltd |
Pharmaceutical compositions resistant to abuse
|
|
GB0909680D0
(en)
|
2009-06-05 |
2009-07-22 |
Euro Celtique Sa |
Dosage form
|
|
EP2445487A2
(en)
|
2009-06-24 |
2012-05-02 |
Egalet Ltd. |
Controlled release formulations
|
|
US9056054B2
(en)
|
2009-06-25 |
2015-06-16 |
Elite Laboratories, Inc. |
Abuse resistant oral dosage forms
|
|
PL2997965T3
(pl)
|
2009-07-22 |
2019-06-28 |
Grünenthal GmbH |
Odporna na manipulacje postać dawkowania opioidów wrażliwych na utlenianie
|
|
WO2011009602A1
(en)
|
2009-07-22 |
2011-01-27 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
|
WO2011041414A1
(en)
|
2009-09-30 |
2011-04-07 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
WO2011079074A1
(en)
|
2009-12-24 |
2011-06-30 |
Acura Phamaceuticals, Inc. |
Pharmaceutical compositions for deterring misuse, abuse, and diversion
|
|
US20110195989A1
(en)
|
2010-02-09 |
2011-08-11 |
Rudnic Edward M |
Controlled Release Formulations of Opioids
|
|
US20130022646A1
(en)
|
2010-02-09 |
2013-01-24 |
Rudnic Edward M |
Controlled Release Formulations of Opioids
|
|
US20120321674A1
(en)
|
2011-02-17 |
2012-12-20 |
Michael Vachon |
Technology for Preventing Abuse of Solid Dosage Forms
|
|
CA2790108C
(en)
|
2010-02-24 |
2016-05-31 |
Cima Labs Inc. |
Abuse-resistant formulations
|
|
CA2808988C
(en)
|
2010-09-02 |
2018-05-01 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising an anionic polymer
|
|
ES2487244T3
(es)
|
2010-09-02 |
2014-08-20 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación que comprende un polímero aniónico
|
|
EP2611426B1
(en)
|
2010-09-02 |
2014-06-25 |
Grünenthal GmbH |
Tamper resistant dosage form comprising inorganic salt
|
|
JP2013537915A
(ja)
|
2010-09-24 |
2013-10-07 |
キューアールエックスファーマ リミテッド |
オピオイドの制御放出製剤
|
|
US20120202838A1
(en)
|
2010-11-04 |
2012-08-09 |
Abbott Laboratories |
Drug formulations
|
|
GB201020895D0
(en)
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
|
WO2012080833A2
(en)
|
2010-12-13 |
2012-06-21 |
Purdue Pharma L.P. |
Controlled release dosage forms
|
|
US8808740B2
(en)
|
2010-12-22 |
2014-08-19 |
Purdue Pharma L.P. |
Encased tamper resistant controlled release dosage forms
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
JP2014505736A
(ja)
|
2011-02-17 |
2014-03-06 |
キューアールエックスファーマ リミテッド |
固体投薬形態の乱用を防止するための技術
|
|
HUE026981T2
(en)
|
2011-03-25 |
2016-08-29 |
Purdue Pharma Lp |
Regulated release dosage forms
|
|
CA2839123A1
(en)
|
2011-07-29 |
2013-02-07 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
|
US20130028972A1
(en)
|
2011-07-29 |
2013-01-31 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
|
EP2755640B1
(en)
|
2011-09-16 |
2017-07-26 |
Purdue Pharma LP |
Tamper resistant pharmaceutical formulations
|
|
ES2583132T3
(es)
|
2011-09-16 |
2016-09-19 |
Purdue Pharma L.P. |
Formulaciones de liberación inmediata resistentes a alteración
|
|
JP2014528437A
(ja)
|
2011-10-06 |
2014-10-27 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
オピオイドアゴニストおよびオピオイドアンタゴニストを含むタンパーレジスタント経口医薬剤形
|
|
JP6246720B2
(ja)
|
2011-10-18 |
2017-12-13 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
アクリルポリマー製剤
|
|
AR088875A1
(es)
|
2011-11-17 |
2014-07-16 |
Gruenenthal Gmbh |
Forma de dosis farmaceutica oral a prueba de manipulacion
|
|
CA2853764C
(en)
|
2011-11-22 |
2017-05-16 |
Watson Pharmaceuticals, Inc. |
Immediate release abuse deterrent tablet
|
|
ES2603278T3
(es)
|
2011-12-09 |
2017-02-24 |
Purdue Pharma Lp |
Formas farmacéuticas de dosificación que comprenden poli (epsilon-caprolactona) y óxido de polietileno
|
|
MX2014015880A
(es)
|
2012-07-06 |
2015-08-05 |
Egalet Ltd |
Composiciones farmaceuticas disuasivas de abuso para liberacion controlada.
|
|
WO2014191397A1
(en)
|
2013-05-29 |
2014-12-04 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|